| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 20,768 | 22,934 | 19,191 | 19,689 | | Cost of Revenue | 5,431 | 5,337 | 6,051 | 6,268 | | | Gross Profit |
-
| 17,597 | 13,140 | 13,421 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,223 | 4,173 | 3,147 | 2,967 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 2,054 | 3,404 | 1,593 | 1,334 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 10,020 | 8,400 | 9,120 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 10,060 | 10,020 | 8,400 | 9,120 | | Interest Expense | 3,781 | 3,913 | 4,015 | 4,470 | | Income Before Tax | 6,279 | 6,107 | 4,385 | 4,650 | | Income Tax Expense | 2,571 | 2,503 | 1,791 | 1,889 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,708 | 3,604 | 2,594 | 2,761 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,708 | 3,604 | 2,594 | 2,761 | | Preferred Stock And Other Adjustments |
-
| 517 | (173) | (173) | | | Net Income Applicable To Common Shares | $3,535 | $4,121 | $2,421 | $2,588 |
|
0.49% Nasdaq 
Income Statement
